The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance

Howard Newville1, Karina M Berg, Jeffrey S Gonzalez

  • 1Department of Psychiatry and Behavioral Health, Mount Sinai St. Luke's, New York, NY, USA, hnewville@chpnet.org.

Insights

Substance use impacts highly active antiretroviral therapy (HAART) adherence, especially with lower depression levels. Continued substance use indicates an unmet treatment need in HIV patients on methadone maintenance.

Area of Science:

  • Public Health
  • Clinical Medicine
  • Psychiatry

Background:

  • Adherence to highly active antiretroviral therapy (HAART) is critical for HIV treatment success.
  • Both substance use and depression are linked to HAART nonadherence, but their combined effect is not well understood.
  • Understanding this interaction can improve interventions for adherence, substance use, and depression.

Purpose of the Study:

  • To investigate the interaction between substance use and depressive symptoms on HAART adherence.
  • Focus on patients undergoing methadone maintenance treatment.

Main Methods:

  • Assessed substance use, depressive symptoms, and HAART adherence in 100 HIV-infected individuals on methadone maintenance.
  • Employed regression analysis with an interaction term for substance use and depressive symptoms.
  • Utilized MODPROBE to analyze significant interactions.

Main Results:

  • Illicit substance use was significantly associated with HAART nonadherence (p=0.043).
  • Cannabis use showed the strongest association with nonadherence (p=0.003).
  • A significant interaction effect was observed: illicit substance use predicted nonadherence in individuals with lower depressive symptoms (p=0.007).

Conclusions:

  • Substance use and depressive symptoms interact to affect HAART adherence, but not synergistically.
  • High rates of continued substance use (51%) highlight an unmet need for treatment.
  • Further research into the interplay of substance use and depression on HAART adherence is necessary.
Abstract

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
428
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
443
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
605